Form 4: Privia Health CFO Executes Sell-to-Cover Transaction

EVP and CFO David Mountcastle sold 5,566 shares of Privia Health Group to satisfy tax obligations related to RSU vesting.

Summary

• David Mountcastle, EVP and Chief Financial Officer of Privia Health Group, Inc., sold 5,566 shares of common stock.
• The transaction occurred on April 2, 2026, at a price of $20.85 per share.
• The sale was a non-discretionary 'sell-to-cover' transaction to satisfy tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Mountcastle retains direct ownership of 214,847 shares, with an additional 8,695 shares held indirectly by his spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was a mandatory tax-related transaction rather than a discretionary divestment.

Positives

• The transaction was non-discretionary and specifically intended to cover tax liabilities, indicating it was not a signal of lack of confidence in the company.

Negatives

• Reduction in direct equity stake held by a key executive.

Risks

• None identified; this is a routine regulatory filing regarding executive compensation tax obligations.

Future Outlook

Not applicable; this is a retrospective disclosure of an insider transaction.

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are standard practice for executives receiving equity-based compensation and do not typically reflect a change in management's outlook on the company's performance.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for executive tax management in the healthcare technology sector.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was non-discretionary and related to tax compliance.

Key Dates

Keywords

Privia Health Group, PRVA, Insider Trading, Form 4, CFO, Equity Compensation